USPTO serial 99227014
ENHANCED PRP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PEREIRA FILHO, JOAO BOSCO
- Law office
- TMO LAW OFFICE 136
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ENHANCED PRP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Heather Kaplan
Lindsay Heather Kaplan TOPSHELF TRADEMARKS LLC8 North Front StreetSuite 2002Kingston, NY 12401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetic ingredient complex composed of hyaluronic acid, silk proteins, chitosan, collagen, platelet rich plasma, platelet rich fibrin, and bone marrow concentrate, or any combination thereof sold as an integral component of non-medicated skincare preparations; Collagen preparations for cosmetics purposes; Cosmetic preparations; Non-medicated skin care preparations | ACTIVE | — |
| 005 | Solutions for medical and clinical use in storing and treating cells, blood and blood components; Blood grouping reagents for medical purposes; Hyaluronic acid for pharmaceutical purposes; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for cellular therapy for the treatment of damaged skin or tissue; Chemical preparations for pharmaceutical or medical purposes, namely, for the preparation of autologous biological products; Biologics in the nature of cells for medical use; Biologics in the nature of pharmaceutical preparations for the treatment of damaged skin or tissue; Biologics in the nature of cells for the treatment of damaged skin or tissue; Biological tissue grafts; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Reagents for medical use; Biological reagents for medical purposes; Anticoagulants; Pharmaceutical preparations for use in regenerative medicine, aesthetic medicine, and dermatology. | ACTIVE | — |
| 010 | Medical devices, namely, tubing and bag assembly set and other similar or related devices, which process and treat human platelets with clinical medical reagents for the purpose of enabling the refrigerated storage of human platelets for blood groups for use in blood transfusions; Blood drawing apparatus; Blood collection needles; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood containers for medical purposes; Blood component separation apparatus for medical purposes; Blood storage bags for medical purposes; Blood tubing sets for medical purposes; Blood collection bags for medical purposes; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical syringes; Hypodermic syringes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 23, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 17, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Feb 17, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Nov 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 10, 2025 | NWAP | NEW APPLICATION ENTERED | — |